Lauren Zierke | Senior Director of Investor Relations |
Mike Mason | President of Lilly Diabetes |
Jeff Emmick | Vice President of Diabetes Product Development |
Ruth Gimeno | Vice President of Diabetes Research & Clinical Investigation |
Seamus Fernandez | Guggenheim |
Chris Schott | JPMorgan |
Steve Scala | Cowen |
Geoff Meacham | Bank of America |
David Risinger | SVB Securities |
Tim Anderson | Wolfe Research |
Mike DiFiore | Evercore ISI |
Vamil Divan | Mizuho Securities |
Andrew Baum | Citi |
Chris Shibutani | Goldman Sachs |
Kerry Holford | Berenberg |
Nishant Gandhi | Truist Securities |
Evan Seigerman | BMO Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the ADA Investor Update. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session with instructions being given at that time. [Operator Instructions] As a reminder, today's conference is being recorded.